Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0002019410-25-000012
Filing Date
2025-08-12
Accepted
2025-08-12 16:59:53
Documents
84
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cai-20250630.htm   iXBRL 10-Q 2643023
2 EX-10.3(A)(2) exhibit103a2-cariswpt2ndam.htm EX-10.3(A)(2) 59509
3 EX-31.1 302 CEO CERTIFICATION ex311-302certificationceo.htm EX-31.1 9338
4 EX-31.2 302 CFO CERTIFICATION ex312-302certificationcfo.htm EX-31.2 9129
5 EX-32.1 906 CEO CERTIFICATION ex321-906certificationceo.htm EX-32.1 4421
6 EX-32.2 906 CFO CERTIFICATION ex322-906certificationcfo.htm EX-32.2 4454
  Complete submission text file 0002019410-25-000012.txt   11225200

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cai-20250630.xsd EX-101.SCH 66028
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cai-20250630_cal.xml EX-101.CAL 69776
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cai-20250630_def.xml EX-101.DEF 467753
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cai-20250630_lab.xml EX-101.LAB 836876
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cai-20250630_pre.xml EX-101.PRE 651217
87 EXTRACTED XBRL INSTANCE DOCUMENT cai-20250630_htm.xml XML 1447723
Mailing Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039
Business Address 750 W JOHN CARPENTER FREEWAY SUITE 800 IRVING TX 75039 (866) 771-8946
Caris Life Sciences, Inc. (Filer) CIK: 0002019410 (see all company filings)

EIN.: 852077369 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42706 | Film No.: 251207673
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)